Dare Bioscience (DARE) Selling, General & Administrative (2013 - 2026)
Dare Bioscience's Selling, General & Administrative was $2.59 million in Q2 2026, up 9.1% from $2.38 million a year earlier.
Powered by 
Analysis
Dare Bioscience (DARE) Selling, General & Administrative (2013 - 2026) Analysis & Trends
On a trailing twelve-month basis, Dare Bioscience's Selling, General & Administrative was $9.05 million through Jun 30, 2026, up 3.7% year-over-year; for FY2025, it came in at $8.76 million, down 4.3% from FY2024.
- Selling, General & Administrative shows a five-year compound annual growth rate of 6.0% (FY2020 to FY2025).
- In earlier years, Selling, General & Administrative was $9.16 million in FY2024 (-24.4%), $12.11 million in FY2023 (+7.7%), $11.24 million in FY2022 (+34.6%) and $8.35 million in FY2021 (+27.5%).
- The Q2 2026 figure marks the highest quarterly Selling, General & Administrative since Q1 2024.
- Compared with a year earlier, Selling, General & Administrative was higher in two of the last seven quarters, with an average decline of 9.6%.
- The best year-over-year quarter for Selling, General & Administrative over five years was Q3 2021 (growth of 63.4%); the worst was Q4 2024 (a decline of 36.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Dare Bioscience | 12.89 Mn | -52.57 Mn | -132,343.00 | 2.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.59 Mn |
| Dec 31, 2025 | 1.58 Mn |
| Sep 30, 2025 | 2.50 Mn |
| Jun 30, 2025 | 2.38 Mn |
| Mar 31, 2025 | 2.31 Mn |
| Dec 31, 2024 | 2.00 Mn |
| Sep 30, 2024 | 2.04 Mn |
| Jun 30, 2024 | 2.45 Mn |
| Mar 31, 2024 | 2.67 Mn |
| Dec 31, 2023 | 3.15 Mn |
| Sep 30, 2023 | 2.70 Mn |
| Jun 30, 2023 | 2.92 Mn |
| Mar 31, 2023 | 3.34 Mn |
| Dec 31, 2022 | 3.23 Mn |
| Sep 30, 2022 | 2.65 Mn |
| Jun 30, 2022 | 2.79 Mn |
| Mar 31, 2022 | 2.57 Mn |
| Dec 31, 2021 | 2.40 Mn |
| Sep 30, 2021 | 2.21 Mn |
| Jun 30, 2021 | 1.80 Mn |
API Access
Dare Bioscience Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=DARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "DARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=DARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();